Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.

Kosaka H, Kinoshita M, Yasuda S, Kakizaki S, Sugimoto R, Sakata J, Yamai K, Hatanaka T, Yamamoto Y, Sato T, Ishikawa T, Morikawa T, Hanaoka J, Mori H, Toyoda H, Sanuki T, Yokoi M, Shibata H, Fukuda K, Kawata K, Amaya K, Ito T, Hidaka M, Naganuma A, Sugimachi K, Toshiyama S, Yamasaki M, Kaibori M

Open source

DOI: 10.1002/ags3.70202
Published: 2026 Jul
Container: Annals of gastroenterological surgery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ags3.70202,
  title = {Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.},
  author = {Kosaka H and Kinoshita M and Yasuda S and Kakizaki S and Sugimoto R and Sakata J and Yamai K and Hatanaka T and Yamamoto Y and Sato T and Ishikawa T and Morikawa T and Hanaoka J and Mori H and Toyoda H and Sanuki T and Yokoi M and Shibata H and Fukuda K and Kawata K and Amaya K and Ito T and Hidaka M and Naganuma A and Sugimachi K and Toshiyama S and Yamasaki M and Kaibori M},
  year = {2026},
  journal = {Annals of gastroenterological surgery},
  doi = {10.1002/ags3.70202},
  url = {https://doi.org/10.1002/ags3.70202}
}

RIS

TY  - JOUR
TI  - Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.
AU  - Kosaka H
AU  - Kinoshita M
AU  - Yasuda S
AU  - Kakizaki S
AU  - Sugimoto R
AU  - Sakata J
AU  - Yamai K
AU  - Hatanaka T
AU  - Yamamoto Y
AU  - Sato T
AU  - Ishikawa T
AU  - Morikawa T
AU  - Hanaoka J
AU  - Mori H
AU  - Toyoda H
AU  - Sanuki T
AU  - Yokoi M
AU  - Shibata H
AU  - Fukuda K
AU  - Kawata K
AU  - Amaya K
AU  - Ito T
AU  - Hidaka M
AU  - Naganuma A
AU  - Sugimachi K
AU  - Toshiyama S
AU  - Yamasaki M
AU  - Kaibori M
PY  - 2026
JO  - Annals of gastroenterological surgery
DO  - 10.1002/ags3.70202
UR  - https://doi.org/10.1002/ags3.70202
ER  -

APA

H, K., M, K., S, Y., S, K., R, S., J, S., K, Y., T, H., Y, Y., T, S., T, I., T, M., J, H., H, M., H, T., T, S., M, Y., H, S., K, F., K, K., K, A., T, I., M, H., A, N., K, S., S, T., M, Y., & M, K. (2026). Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.. Annals of gastroenterological surgery. https://doi.org/10.1002/ags3.70202

Source records

pubmed · retrieved 2026-09-26T16:51:28.887Z